EcoDrugPlus

Ensembl ID : ENSSVLG00005018104
Gene Symbol: -
Cross references: -
75 Possible Orthologues:

Ensembl ID : ENSSVLG00005004101
Gene Symbol: -
Cross references: -
291 Possible Orthologues:

Ensembl ID : ENSSVLG00005004076
Gene Symbol: -
Cross references: -
279 Possible Orthologues:

Ensembl ID : ENSSVLG00005002918
Gene Symbol: -
Cross references: -
149 Possible Orthologues:

Ensembl ID : ENSSVLG00005001730
Gene Symbol: -
Cross references: -
731 Possible Orthologues:

Ensembl ID : ENSSVLG00005000204
Gene Symbol: -
Cross references: -
420 Possible Orthologues:

Ensembl ID : ENSSVLG00005021615
Gene Symbol: -
Cross references: -
295 Possible Orthologues:

Ensembl ID : ENSSVLG00005006809
Gene Symbol: -
Cross references: -
266 Possible Orthologues:

Ensembl ID : ENSSVLG00005000178
Gene Symbol: -
Cross references: -
182 Possible Orthologues:

Ensembl ID : ENSSVLG00005003428
Gene Symbol: -
Cross references: -
178 Possible Orthologues:

Ensembl ID : ENSSVLG00005001248
Gene Symbol: -
Cross references: -
231 Possible Orthologues:

Ensembl ID : ENSSVLG00005001418
Gene Symbol: -
Cross references: -
193 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).